31. Escherichia coli-induced immune paralysis is not exacerbated during chronic filarial infection.
Buerfent BC, Gondorf F, Wohlleber D, Schumak B, Hoerauf A, Hübner MP
Immunology. 2015 May .
PMID: 25521437 [PubMed - in process]
32. Global transcriptional characterization of CD8+ T cell memory.
Böttcher J, Knolle PA
Semin Immunol. 2015 Feb .
PMID: 25841628 [PubMed - in process]
33. The role of hepatic immune regulation in systemic immunity to viral infection.
Knolle PA, Böttcher J, Huang LR
Med Microbiol Immunol. 2015 Feb .
PMID: 25523194 [PubMed - in process]
34. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.
Kelwick R, Wagstaff L, Decock J, Roghi C, Cooley LS, Robinson SD, Arnold H, Gavrilović J, Jaworski DM, Yamamoto K, Nagase H, Seubert B, Krüger A, Edwards DR
Int J Cancer. 2015 Feb 15.
PMID: 25099234 [PubMed - in process]
35. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Kostova Y, Mantwill K, Holm PS, Anton M
Cancer Gene Ther. 2015 Jan .
PMID: 25501992 [PubMed - in process]
36. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
Berchtold S, Grünwald B, Krüger A, Reithmeier A, Hähl T, Cheng T, Feuchtinger A, Born D, Erkan M, Kleeff J, Esposito I
Cancer Lett. 2015 Jan 28.
PMID: 25449434 [PubMed - in process]
37. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.
Seubert B, Grünwald B, Kobuch J, Cui H, Schelter F, Schaten S, Siveke JT, Lim NH, Nagase H, Simonavicius N, Heikenwalder M, Reinheckel T, Sleeman JP, Janssen KP, Knolle PA, Krüger A
Hepatology. 2015 Jan .
PMID: 25131778 [PubMed - in process]
38. Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.
Lang PA, Meryk A, Pandyra AA, Brenner D, Brüstle A, Xu HC, Merches K, Lang F, Khairnar V, Sharma P, Funkner P, Recher M, Shaabani N, Duncan GS, Duhan V, Homey B, Ohashi PS, Häussinger D, Knolle PA, Honke N, Mak TW, Lang KS
Cell Death Differ. 2015 Jan .
PMID: 25257173 [PubMed - in process]
39. Nanomagnetic activation as a way to control the efficacy of nucleic Acid delivery.
Grześkowiak BF, Sánchez-Antequera Y, Hammerschmid E, Döblinger M, Eberbeck D, Woźniak A, Słomski R, Plank C, Mykhaylyk O
Pharm Res. 2015 Jan .
PMID: 25033763 [PubMed - in process]
40. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
Mykhaylyk O, Sanchez-Antequera Y, Vlaskou D, Cerda MB, Bokharaei M, Hammerschmid E, Anton M, Plank C
Methods Mol Biol. 2015 .
PMID: 25319646 [PubMed - in process]